| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Midaglia Fernandez, Luciana |
| dc.contributor.author | Mulero Carrillo, Patricia |
| dc.contributor.author | Montalban, Xavier |
| dc.contributor.author | Graves, Jennifer |
| dc.contributor.author | Hauser, Stephen L. |
| dc.contributor.author | Julian, Laura |
| dc.date.accessioned | 2020-03-13T12:29:12Z |
| dc.date.available | 2020-03-13T12:29:12Z |
| dc.date.issued | 2019-08-30 |
| dc.identifier.citation | Midaglia L, Mulero P, Montalban X, Graves J, Hauser SL, Julian L, et al. Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study. J Med Internet Res. 2019 Aug 30;21(8):e14863. |
| dc.identifier.issn | 1438-8871 |
| dc.identifier.uri | https://hdl.handle.net/11351/4730 |
| dc.description | Smartphone; Multiple sclerosis; Patient adherence |
| dc.description.abstract | Background: Current clinical assessments of people with multiple sclerosis are episodic and may miss critical features of functional fluctuations between visits.
Objective: The goal of the research was to assess the feasibility of remote active testing and passive monitoring using smartphones and smartwatch technology in people with multiple sclerosis with respect to adherence and satisfaction with the FLOODLIGHT test battery.
Methods: People with multiple sclerosis (aged 20 to 57 years; Expanded Disability Status Scale 0-5.5; n=76) and healthy controls (n=25) performed the FLOODLIGHT test battery, comprising active tests (daily, weekly, every two weeks, or on demand) and passive monitoring (sensor-based gait and mobility) for 24 weeks using a smartphone and smartwatch. The primary analysis assessed adherence (proportion of weeks with at least 3 days of completed testing and 4 hours per day passive monitoring) and questionnaire-based satisfaction. In-clinic assessments (clinical and magnetic resonance imaging) were performed.
Results: People with multiple sclerosis showed 70% (16.68/24 weeks) adherence to active tests and 79% (18.89/24 weeks) to passive monitoring; satisfaction score was on average 73.7 out of 100. Neither adherence nor satisfaction was associated with specific population characteristics. Test-battery assessments had an at least acceptable impact on daily activities in over 80% (61/72) of people with multiple sclerosis. |
| dc.language.iso | eng |
| dc.publisher | JMIR Publications |
| dc.relation.ispartofseries | Journal of Medical Internet Research;21(8) |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Esclerosi múltiple |
| dc.subject | Pacients - Cooperació |
| dc.subject | Telèfons intel·ligents |
| dc.subject.mesh | Multiple Sclerosis |
| dc.subject.mesh | Patient Compliance |
| dc.subject.mesh | Wearable Electronic Devices |
| dc.title | Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.2196/14863 |
| dc.subject.decs | esclerosis múltiple |
| dc.subject.decs | cumplimiento del paciente |
| dc.subject.decs | dispositivos electrónicos ponibles |
| dc.relation.publishversion | https://www.jmir.org/2019/8/e14863/ |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.authoraffiliation | [Midaglia L] Servei de Neuroimmonologia clínica, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. [Mulero P] Servei de Neuroimmonologia clínica, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. [Montalban X] Neuroimmonologia clínica, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Hospital Universitari Vall d’Hebron, Barcelona, Spain. Departament de Neurologia, Universitat de Toronto, Toronto, Canadà. [Graves J] Department of Neurology, University of California, San Diego, USA. [Hauser SL] Department of Neurology, University of California, San Francisco,USA. [Julian L] Genentech Inc, South San Francisco, USA |
| dc.identifier.pmid | 31471961 |
| dc.identifier.wos | 000483306800001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |